News

Lawdragon has recognized seven Seeger Weiss partners—Christopher Seeger, Stephen Weiss, Parvin Aminolroaya, Ben Barnett, David Buchanan, Shauna Itri, and Jennifer Scullion—in its 2027 Lawdragon 500 Leading Litigators in America guide. The guide highlights attorneys whose courtroom, investigative, and regulatory work has produced real impacts for the clients they represent, with many honorees credited with influencing entire […]

Seeger Weiss has been recognized as a finalist for Litigation Department of the Year, Products Liability/Mass Torts at the New Jersey Law Journal’s 2026 New Jersey Legal Awards. This recognition reflects a year of leadership appointments and firm growth across the department’s most significant matters. In March 2025, founding partner Christopher A. Seeger was appointed […]

Seeger Weiss LLP has been appointed as a member of the Interim Plaintiffs’ Steering Committee in In re Garden Grove Chemical Plant Evacuation, a consolidated class action pending in the U.S. District Court for the Central District of California. Seeger Weiss founding partners Christopher A. Seeger and Stephen A. Weiss are leading the firm’s involvement […]

Meta has agreed to settle claims brought by 29 State Attorneys General in the midst of a federal bellwether trial in the Social Media Adolescent Addiction/Personal Injury Products Liability multi-district litigation (MDL). Seeger Weiss Founding Partner Christopher A. Seeger serves as Counsel to the Co-Lead Counsel and Settlement Counsel in the MDL for the school […]

Seeger Weiss is proud to announce that fifteen of our attorneys have been recognized in the 2027 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and class actions, personal […]

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]